NewcelX (NCEL) Current Assets (2019 - 2025)
NewcelX (NCEL) posted quarterly Current Assets of $3.2 million for Q4 2025, up 307.95% year-over-year from $780000.0 in Q4 2024, and up 796.34% quarter-over-quarter from $355000.0 in Q2 2025.
NewcelX (NCEL) Current Assets (2019 - 2025) Analysis & Trends
NewcelX (NCEL) has reported Current Assets for 7 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 307.95% year-over-year to $3.2 million; the TTM figure through Dec 2025 stood at $3.2 million (up 307.95% YoY), while the FY2025 annual figure was $3.2 million, up 307.95% from the prior year.
- Current Assets improved to $3.2 million in Q4 2025 per NCEL's latest filing, from $355000.0 in the prior quarter.
- Across five years, Current Assets topped out at $8.2 million in Q2 2021 and bottomed at $355000.0 in Q2 2025.
- Historically, Current Assets has averaged $2.7 million across 5 years, with a median of $1.8 million in 2022.
- Annual changes were most pronounced in 2021 — Current Assets surged 2809.42% — and 2022, when it tumbled 75.46%.
- NewcelX's Current Assets stood at $5.7 million in 2021, then plunged by 63.17% to $2.1 million in 2022, then dropped by 24.24% to $1.6 million in 2023, then slumped by 51.16% to $780000.0 in 2024, then jumped by 307.95% to $3.2 million in 2025.
- Business Quant data shows NCEL's Current Assets at $3.2 million in Q4 2025, $355000.0 in Q2 2025, and $780000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 1.76 Bn |
| 10 | NewcelX | 12.54 Mn | 10.34 Mn | - | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Jun 30, 2025 | 355,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Dec 31, 2022 | 2.11 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Jun 30, 2021 | 8.24 Mn |
| Dec 31, 2020 | 196,711.00 |
| Dec 31, 2019 | 381,746.00 |